Abstract
Osteoporosis is a diffuse skeletal disease in which a decrease in bone strength leads to an increased risk of fractures. A wide variety of types of bone densitometry measurements are available, including quantitative computed tomography measurements of the spine, quantitative ultrasound devices for measurements of the heel and other peripheral sites and dual-energy X-ray absorptiometry (DXA) for measurement of bone mineral density (BMD) at the lumbar spine, proximal femur, forearm and total body scans. Compared with alternative bone densitometry techniques, hip and spine DXA examinations have a number of advantages that include a consensus that BMD results can be interpreted using the World Health Organization T score definition of osteoporosis, a proven ability to predict fracture risk, proven effectiveness at targeting anti-fracture therapies, and the ability to monitor response to treatment. However, in recent years, the authors have raised some important questions about the objective limits of this method that have led to doubts about its effectiveness in terms of clinical outcome.
References
NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785–795
Nuti R, Brandi LM, Isaia G et al (2009) New perspectives on the definition and the management of severe osteoporosis: the patient with two or more fragility fractures. J Endocrinol Invest Oct 32(9):783–788
Fogeman I, Blake GM (2000) Different approaches to bone densitometry. J Nucl Med 41:2015–2025
De Klerk G, van der Velde D, van der Palen J et al (2009) The usefulness of dual energy X-ray and laser absorptiometry of the calcaneus versus dual energy X-ray absorptiometry of hip and spine in diagnosing manifest osteoporosis. Arch Orthop Trauma Surg 129:251–257
Lu Y, Genant HK, Shepherd J et al (2001) Classification of osteoporosis based on bone mineral densities. J B Miner Res 16:901–910
Kanis JA, Gluer CC (2000) An update on the diagnosis and assessment of osteoporosis with densitometry. Osteoporos Int 11:192–202
International Society of Clinical Densitometry (ISCD) (2005) Official positions of the international society for clinical densitometry
Andreoli A, Bazzocchi A, Celi M et al. (2011) Relationship between body composition, body mass index and bone mineral density in a large population of normal, osteopenic and osteoporotic women. Radiol Med
Hamdy RC, Petak SM, Lenchik L (2002) Which central dual X-ray absorptiometry skeletal sites and regions of interest should be used to determine the diagnosis of osteoporosis? J Clin Densitomet 5:S11–S17
Blake GM, Fogelman I (2009) The clinical role of dual energy X-ray absorptiometry. Europ J Radiol 71:406–414
Muraki S, Yamamoto S, Ishibashi H (2004) Impact of degenerative spinal diseases on bone mineral density of the lumbar spine in elderly women. Osteoporos Int 15:724–728
Arabi A, Baddoura R et al (2007) Discriminative ability of dual-energy X-ray absorptiometry site selection in identifying patients with osteoporotic fractures. Bone 40:1060–1065
Liu G, Peacock M et al (1997) Effect of osteoarthritis in the lumbar spine and hip on bone mineral density and diagnosis of osteoporosis in elderly men and women. Osteoporos Int 7:564–569
Bouxsein ML, Seeman E (2009) Quantifying the material and structural determinants of bone strength. Best Prac Res Clin Rheumatol 23:741–753
Briot K (2013) DXA parameters: beyond bone mineral density. Jt B Spine 80:265–269
Conflict of interest
The authors declare that they have no conflict of interest
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Celi, M., Rao, C., Scialdoni, A. et al. Bone mineral density evaluation in osteoporosis: why yes and why not?. Aging Clin Exp Res 25 (Suppl 1), 47–49 (2013). https://doi.org/10.1007/s40520-013-0074-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40520-013-0074-1